Matches in Nanopublications for { <http://rdf.disgenet.org/resource/nanopub/NP462479.RAFz0vhSe8uTZkAuZHABAj4y-FTAhLntpvoVs1t_53DbI130_assertion> ?p ?o ?g. }
Showing items 1 to 6 of
6
with 100 items per page.
- NP462479.RAFz0vhSe8uTZkAuZHABAj4y-FTAhLntpvoVs1t_53DbI130_assertion type Assertion NP462479.RAFz0vhSe8uTZkAuZHABAj4y-FTAhLntpvoVs1t_53DbI130_head.
- NP462479.RAFz0vhSe8uTZkAuZHABAj4y-FTAhLntpvoVs1t_53DbI130_assertion description "[Therefore, decreased REPS2 expression during prostate cancer progression, observed in earlier work, may result in enhanced EGF receptor expression and signalling, which could add to the androgen-independent state of advanced prostate cancer.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP462479.RAFz0vhSe8uTZkAuZHABAj4y-FTAhLntpvoVs1t_53DbI130_provenance.
- NP462479.RAFz0vhSe8uTZkAuZHABAj4y-FTAhLntpvoVs1t_53DbI130_assertion evidence source_evidence_literature NP462479.RAFz0vhSe8uTZkAuZHABAj4y-FTAhLntpvoVs1t_53DbI130_provenance.
- NP462479.RAFz0vhSe8uTZkAuZHABAj4y-FTAhLntpvoVs1t_53DbI130_assertion SIO_000772 15455380 NP462479.RAFz0vhSe8uTZkAuZHABAj4y-FTAhLntpvoVs1t_53DbI130_provenance.
- NP462479.RAFz0vhSe8uTZkAuZHABAj4y-FTAhLntpvoVs1t_53DbI130_assertion wasDerivedFrom befree-2016 NP462479.RAFz0vhSe8uTZkAuZHABAj4y-FTAhLntpvoVs1t_53DbI130_provenance.
- NP462479.RAFz0vhSe8uTZkAuZHABAj4y-FTAhLntpvoVs1t_53DbI130_assertion wasGeneratedBy ECO_0000203 NP462479.RAFz0vhSe8uTZkAuZHABAj4y-FTAhLntpvoVs1t_53DbI130_provenance.